Clinical Trial Update: An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating BG-89894 tablets in patients with advanced MTAP-deleted solid tumors; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Metastatic Mtap-deleted Solid Tumors

Drugs mentioned

• BG-89894

Snippet

Sponsor: BeOne Medicines | Conditions: Advanced or Metastatic MTAP-deleted Solid Tumors | Phase 1 | Status: ACTIVE_NOT_RECRUITING